In our latest interview in collaboration with SLAS_Org, we speak to Magdalena Kasendra from CincyChildrens about organoid technology and how it has the power to revolutionize healthcare! Read the full interview below!👇
Sponsored Content by Society for Laboratory Automation and Screening Feb 1 2023 Thought LeadersMagdalena KasendraDirector of Research and DevelopmentCenter for Stem Cell and Organoid Medicine In this interview, we speak to Magdalena Kasendra, Director of Research and Development at the CuSTOM Accelerator, about organoid technology and how it has the power to revolutionize healthcare through the development of new, effective drugs and tissue replacement therapies.
What I find most exciting about this field is the potential for organoids to revolutionize healthcare. The ability to grow functional, three-dimensional organoids in a dish opens up a whole new world of possibilities for studying disease, developing new therapies, and understanding how cells and tissues function.
Our ultimate goal is to improve human health, and I am dedicated to ensuring that our research has a real impact on patients. We are constantly seeking new collaborations and partnerships to help us achieve this goal and bridge the gap between basic research and clinical application. Our efforts at CuSTOM are focused on utilizing organoids to improve human health. We believe this research can transform the way we treat a wide range of human diseases and disorders in the future. By creating new treatments and therapies tailored to the individual patient, we aim to enhance the effectiveness and safety of these treatments and ultimately unlock better healthcare for all.
Furthermore, our multidisciplinary team plays a critical role in bridging the gap between basic research and clinical application and accelerates the translation of new discoveries into treatments and therapies that can improve health outcomes for millions worldwide. It is a key driver in advancing medical research and providing innovative solutions to improve patient outcomes and quality of life.The drug discovery sector has seen incredible advancements in recent years.
You are giving a talk at SLAS 2023 titled 'Engineering next generation organoids for biomedical research and drug development'. Please can you talk us through what you will be covering in this talk and what listeners can expect to learn? Related StoriesIn my talk at SLAS 2023, I will discuss the latest advances in organoid technology and how we are using these advances to improve biomedical research and drug development.
With continued research and investment, we can hope to see personalized medicine becoming more commonplace in healthcare settings and see this approach's benefits reach more patients. This can lead to more effective and efficient treatments, fewer side effects, and improved patient outcomes. Additionally, personalized medicine can help to reduce healthcare costs by avoiding unnecessary treatments and reducing the number of ineffective drugs.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Bride Wore Custom Vivienne Westwood To Her Lush Garden Wedding Overlooking The Tuscan HillsEven though the bride and groom had to postpone multiple times due to the pandemic, they never gave up on their dream wedding. They felt strongly about the fact that their original venue – Borgo Santo Pietro – was the only option when it came to the where. Similarly, Vivienne Westwood was the only designer the bride ever considered for her dress.
Read more »
Asda's make your own pizzas look very different this monthAsda shoppers can custom make their own pizzas at many stores across the UK
Read more »
How to add 'sizzle' to meat-free productsFirms are creating artificial animal fats that they promise will make meat-free products taste better.
Read more »
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionAAV gene therapy for ocular disease has become a reality with the market authorisation of LuxturnaTM for RPE65-linked inherited retinal degenerations and many AAV gene therapies currently undergoing phase III clinical trials. Many ocular disorders have a mitochondrial involvement from primary mitochondrial disorders such as Leber hereditary optic neuropathy (LHON), predominantly due to mutations in genes encoding subunits of complex I, to Mendelian and multifactorial ocular conditions such as dominant optic atrophy, glaucoma and age-related macular degeneration. In this study, we have optimised the nuclear yeast gene, NADH-quinone oxidoreductase (NDI1), which encodes a single subunit complex I equivalent, creating a candidate gene therapy to improve mitochondrial function, independent of the genetic mutation driving disease. Optimisation of NDI1 (ophNdi1) substantially increased expression in vivo, protected RGCs and increased visual function, as assessed by optokinetic and photonegative response, in a rotenone-induced murine model. In addition, ophNdi1 increased cellular oxidative phosphorylation and ATP production and protected cells from rotenone insult to a significantly greater extent than wild type NDI1. Significantly, ophNdi1 treatment of complex I deficient patient-derived fibroblasts increased oxygen consumption and ATP production rates, demonstrating the potential of ophNdi1 as a candidate therapy for ocular disorders where mitochondrial deficits comprise an important feature.
Read more »
'Spleen-on-a-chip' yields insight into sickle cell diseaseEvery day, billions of red blood cells pass through the spleen, an organ that is responsible for filtering out old or damaged blood cells. This task is made more difficult when the blood cells are misshapen, as they are in patients with sickle cell disease, which affects millions of people throughout the world. Sickled blood cells can clog the spleen's filters, leading to a potentially life-threatening situation.
Read more »
Ten Hag refuses to sanction loan deal for Man Utd defensive duo after shock Inter 'enquiry'Inter Milan have enquired about the availability of Manchester United defenders Harry Maguire and Victor Lindelof, according to reports.
Read more »